Financials
- Market Capitalization 1.16 B
- Employee 142
- Founded 2018
- CEO Steve Harr
- Website www.sana.com
- Headquarter Delaware, United States
- FIGI BBG00N5BMH61
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2319 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 14.15 USD | -1.60% | +0.43% | -12.92% | +25.22% | 1.21 B USD | ||
| 2331 | JANX Janux Therapeutics, Inc. - Common Stock | 19.70 USD | -0.51% | +5.74% | +23.05% | -18.05% | 1.20 B USD | ||
| 2358 | KURA Kura Oncology, Inc. - Common Stock | 12.93 USD | -1.67% | -0.23% | +37.26% | +58.65% | 1.15 B USD | ||
| 2386 | SLDB Solid Biosciences Inc. - Common Stock | 10.25 USD | -1.63% | +1.99% | +15.95% | +79.82% | 1.10 B USD |